Related Experiment Video
Updated: Mar 9, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Pharmacological rescue of diabetic skeletal stem cell niches
Ruth Tevlin1,2, Eun Young Seo1,2, Owen Marecic1,2
1Hagey Laboratory for Pediatric Regenerative Medicine and Department of Surgery, Stanford University, Palo Alto, CA 94305, USA.
Abstract:
Diabetes mellitus (DM) is a metabolic disease frequently associated with impaired bone healing. Despite its increasing prevalence worldwide, the molecular etiology of DM-linked skeletal complications remains poorly defined. Using advanced stem cell characterization techniques, we analyzed intrinsic and extrinsic determinants of mouse skeletal stem cell (mSSC) function to identify specific mSSC niche-related abnormalities that could impair skeletal repair in diabetic (Db) mice. We discovered that high serum concentrations of tumor necrosis factor-α directly repressed the expression of Indian hedgehog (Ihh) in mSSCs and in their downstream skeletogenic progenitors in Db mice. When hedgehog signaling was inhibited during fracture repair, injury-induced mSSC expansion was suppressed, resulting in impaired healing. We reversed this deficiency by precise delivery of purified Ihh to the fracture site via a specially formulated, slow-release hydrogel. In the presence of exogenous Ihh, the injury-induced expansion and osteogenic potential of mSSCs were restored, culminating in the rescue of Db bone healing. Our results present a feasible strategy for precise treatment of molecular aberrations in stem and progenitor cell populations to correct skeletal manifestations of systemic disease.
Insights
Diabetes impairs bone healing by reducing Indian hedgehog (Ihh) signaling in skeletal stem cells. Restoring Ihh levels with hydrogel delivery effectively rescued bone repair in diabetic mice.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Metabolic Diseases
Background:
- Diabetes mellitus (DM) is linked to poor bone healing, but the underlying molecular mechanisms are unclear.
- Skeletal stem cell (SSC) dysfunction is implicated in diabetic skeletal complications.
- Identifying specific molecular defects in diabetic SSCs is crucial for therapeutic development.
Purpose of the Study:
- To investigate molecular abnormalities in mouse skeletal stem cells (mSSCs) from diabetic mice.
- To determine the role of Indian hedgehog (Ihh) signaling in impaired bone healing in diabetes.
- To develop a targeted therapy to restore bone healing in diabetic conditions.
Main Methods:
- Advanced stem cell characterization techniques were used to analyze mSSC function in diabetic mice.
- The impact of tumor necrosis factor-alpha (TNF-α) on Ihh expression in mSSCs was assessed.
- Fracture repair was studied with and without Ihh inhibition and with Ihh delivery via hydrogel.
Main Results:
- High serum TNF-α in diabetic mice repressed Ihh expression in mSSCs and progenitors.
- Inhibition of hedgehog signaling during fracture repair suppressed mSSC expansion and impaired healing.
- Delivery of exogenous Ihh via a slow-release hydrogel restored mSSC function and rescued bone healing.
Conclusions:
- TNF-α-mediated repression of Ihh signaling is a key mechanism for impaired bone healing in diabetes.
- Targeted delivery of Ihh can restore mSSC function and correct skeletal defects in diabetic mice.
- This study offers a therapeutic strategy for treating skeletal complications associated with systemic diseases.
Related Concept Videos
Stem Cell Niche
iPS Cell Differentiation
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Culture

